• An autonomous lab combining OpenAI’s GPT-5 with Ginkgo Bioworks’ cloud automation cut cell-free protein synthesis costs by 40% through closed-loop experimentation.
Article Summaries:
- An autonomous laboratory that merges OpenAI’s GPT‑5 with Ginkgo Bioworks’ cloud‑based automation platform has reduced the cost of cell‑free protein synthesis by 40 %. The system employs closed‑loop experimentation, allowing GPT‑5 to design, run, and analyze reactions in real time while Ginkgo’s infrastructure manages the physical execution. The cost savings stem from more efficient reagent use, faster iteration cycles, and automated data analysis. This development could accelerate protein‑engineering projects, lower barriers for research labs, and broaden access to rapid, scalable protein production.
Sources: